Hepatitis C infection: A review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting

Jundishapur Journal of Microbiology

Volumn 4, Issue 1, 2011, Pages 1-9

  Alavi, Seyed Mohammad ^a   Hajiani, Eskandar ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Health care workers; Hepatitis C virus; Occupational exposure

Indexed keywords

ALPHA INTERFERON;

ANTIVIRAL THERAPY; CELLULAR IMMUNITY; CLINICAL FEATURE; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PERSONNEL; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN RELATION; HUMORAL IMMUNITY; INFECTION PREVENTION; INFECTION RISK; IRAN; OCCUPATIONAL EXPOSURE; PLACENTAL TRANSFER; PREVALENCE; PRIMARY HEALTH CARE; REVIEW; VIRUS DETECTION; VIRUS ENTRY; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; WOUND CARE;

HEPATITIS C VIRUS;

EID: 78649719849     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Bonkovsky HL, Mehta S. Hepatitis C: A review and update. J Am Acad Dermatol. 2001; 44(2): 159-82.
2. Alavian SM, Abidi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005; 8 (2): 84-90.
3. Alavi SM, Alavi L. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006). J Infect Public Health. 2009; 2: 47-51.
4. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Risk factors for hepatocellular carcinoma in Southern Iran. Saudi Med J. 2005; 26(6): 974-7.
5. Ray SC, Thomas DL, Hepatitis C. In: Mandell GL, Bennett JE, Dolin R. (eds), Principle and practice of infectious diseases. 7th ed, USA, Philadelphia, Churchill Livingstone. 2010: 2157-94.
6. Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Vir Hep. 2002; 9(2): 84-100.
7. Marranconi FV, Mecenero GP, Pellizzer MC, et al. HCV infection after accidental needle stick injury in health-care workers. Infection. 1992; 20: 111.
8. Harris SA. Occupational exposures in emergency medical service providers and knowledge of and compliance with universal precautions. Am J Infect Control. 2010; 38(2): 86-94.
9. Sulkowski MS, Ray SC, Thomas DL. Needle sticks transmission of hepatitis C. JAMA. 2002; 287: 2406-13.
10. http://en.wikipedia.org/wiki/Lean.
11. Asadi-Lari M, Sayyari AA, Akbari ME, Gray D. Public health improvement in Iranlessons from the last 20 years. Pub Health. 2004; 118(6): 395-402.
12. Alavi SM. Relative frequency of infections among hospitalized injecting drug user HIV positive patients in Razi hospital, Ahvaz, SW Iran (2001-2003). Jundishapur J Microbiol. 2008; 1(1): 6-9.
13. Alavi SM, Etemadi A. HIV/HBV, HIV/HCV and HIV/HTLV-1 co-infection among injection drug user patients hospitalized at the infection ward of a training hospital in Ahvaz, Iran. Pakistan J Med Sci. 2007; 23(4): 510-3.
14. Alavi SM, Behdad F. Seroprevalence study of hepatitis C and hepatitis B virus among hospitalized intravenous drug users in Ahvaz, Iran (2002-2006). Hepat Mon. 2010; 10(2): 101-4.
15. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Hepatitis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol. 2006; 12(43): 7025-8.
16. Zanetti AR, Tanzia E, Newellb ML. Mother-to-infant transmission of hepatitis C virus. J Hepatol. 1999; 31: 96-100.
17. Sartori MG, La Terra M, Aglietta A, Manzin C, Navino G. Transmission of hepatitis C via blood splash into conjunctiva. Scand J Infect Dis. 1993; 25: 270-1.
18. Hajiani E, Hashemi SJ. Risk of hepatitis C virus transmission following upper gastrointestinal endoscopy. Yafteh. 2005; 3(29): 110-6.
19. Shahbazian H, Hajiani E, Ehsanpour A. Patient and graft survival of kidney allograft recipients with hepatitis C virus infection: A case-control study. Urol J. 2008; 5(3): 249-52.
20. Thompson ND. Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic-Nevada, 2007. MMWR Morb Mortal Wkly Rep. 2008; 57 (19):513-7.
21. Martinez-Bauer E, Forns X, Armelles M. Hospital admission is a relevant source of hepatitis C virus, acquisition in Spain. J Hepatol. 2008; 48: 20-7.
22. Dumpis U, Kovalova Z, Jansons I, et al. An outbreak of HBV and HICV infection in a paediatric oncology ward: epidemiological investigations and prevention of further spread. J Med Virol. 2003; 69: 331-8.
23. Ross RS, Viazov S, Khudyakov YE, et al. Transmission of hepatitis C virus in an orthopedic hospital ward. J Med Virol. 2009; 81: 249-57.
24. Patel PR, Larson AK. Castel AD. Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies. JAMA. 2006; 296: 2005-11.
25. Bari A, Akhtar S, Rahbar MH, Luby SP. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Trop Med Int Health 2001; 6: 732-8.
26. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med.1996; 334: 555-60.
27. Villano SA, Vlahov D, Nelson KF, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology. 1999; 29: 908-14.
28. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000; 6: 578-82.
29. Nelson D R. The immunopathogenesis of hepatitis C virus infection. Clin Liver Dis. 2001; 5: 931-53.
30. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med.1995; 122: 169-73.
31. Mowla K, Hajiani E. Prevalence of hepatitis C virus infection in patients with systemic lupus erythematosus: A case-control study. Hepat Mon. 2008; 8(1): 41-4.
32. Mignogna MD, Fedele S, Lo Russo L, Ruoppo E, Adamo D, Lo Muzio L. Extrahepatic manifestations of HCV infection: the slowly unraveling picture of oral lichen planus. J Hepatol. 2002; 37: 412-3.
33. Chang KM, Thimme R, Melpolder JJ, et al. Differential CD4 (+) and CD8 (+) T-cell responsiveness in hepatitis C virus infection. Hepatology. 2001; 33: 267-76.
34. Eckels DD, Wang H, Bian TH, Tabatabai N, Gill JC. Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 Tcells in HCV infection. Immunol Rev. 2000; 174: 90-7.
35. Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2009; 5(2): 293-302.
36. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan province, south-west of Iran: a case-control study. World J Gastroenterol. 2006; 12(30): 4884-7.
37. Hajiani E, Hashemi SJ, Masjedizadeh R. Seroprepidemiology of hepatitis B in Khuzestan province, southwest Iran. Hepat Mon. 2009; 9(1): 34-8.
38. Centers for Disease Control and Prevention. Updated US Public Health Service guidelines for the management of occupational exposures to hepatitis B virus, HCV, and HIV and recommendations for post exposure prophylaxis. Morb Mortal Wkly Rep. 2001; 50: 1-52.
39. Alvarado-Ramy F, Alter MJ, Bower W, et al. Management of occupational exposures to hepatitis C virus: current practice and controversies. Infect Control Hosp Epidemiol. 2001; 22: 53-5.
40. Nakano Y, Kiyosawa K, Sodeyama T, et al. Acute hepatitis C transmitted by needle stick accident despite short duration interferon treatment. J Gastroenterol Hepatol. 1995; 10: 609-11.
41. Henderson DK. HIV post exposure prophylaxis in the 21st century. Emerg Infect Dis. 2001; 7: 254-8.
42. Beltrami EM, Williams IT, Shapiro CN, Chamberland ME. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev. 2000; 13: 385-407.
43. Gerberding JL. Provider-to-patient HIV transmission: how to keep it exceedingly rare. Ann Intern Med. 1999; 130: 64-5.
44. Mehta A. Interventions to reduce needle stick injuries at a tertiary care centre. Indian J Med Microbiol. 2010; 28(1): 17-20.
45. Garner JS. Guideline for isolation precautions in hospitals. The hospital infection control practices advisory committee. Infect Control Hosp Epidemiol. 1996; 17: 53-80.
46. Beekmann SE, Vlahov D, Koziol DE, McShalley ED, Schmitt JM, Henderson DK. Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. Clin Infect Dis. 1994; 18: 562-9.
47. Cody SH, Nainan OV, Garfein RS, et al. HCV transmission from an anesthesiologist to a patient. Arch Intern Med. 2002; 162: 345-50.
48. Thorburn D. Public health laboratory service. Hepatitis C look-back exercise. Commun Dis Rep Wkly. 2000; 10: 203-6.
49. Heptonstall J. Surgeons who test positive for hepatitis C should be transferred to low risk duties. Rev Med Virol. 2000; 10: 75-8.
50. Henderson DK, AIDS/tuberculosis subcommittee of the society for healthcare epidemiology of America. Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. Infect Control Hosp Epidemiol. 1997; 18: 349-63.